← All stocks

Glucotrack, Inc.

GCTK No buying or selling
CIK 0001506983 #5509 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

8 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
BALLANTYNE JOHN
Director
2,747,717
$3.46M
+5,287%
John A. Ballantyne Revocable Living Trust dated 08/01/2017 entity
10% owner
2,743,591
$3.46M
+5,279%
Balo Andrew K
Director
4,692
$5.91K
Malave Luis
Director
4,058
$5.11K
Carter Erin Catherine
Director
2,148
$2.71K
Fischell Robert
Director
2,045
$2.58K
+273.9%
Danzig Allen
Director
1,922
$2.42K
+353.3%
Goode Paul
Chief Executive Officer
339
$427.14

No percentages here. This company's share count has moved by a factor of 28.4 over the window, from 899,410 to 25,585,853 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 4
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 2,134
History held since 15 Nov 2016